IT8320435A0 - Composizione per il trattamento dell'acne. - Google Patents

Composizione per il trattamento dell'acne.

Info

Publication number
IT8320435A0
IT8320435A0 IT8320435A IT2043583A IT8320435A0 IT 8320435 A0 IT8320435 A0 IT 8320435A0 IT 8320435 A IT8320435 A IT 8320435A IT 2043583 A IT2043583 A IT 2043583A IT 8320435 A0 IT8320435 A0 IT 8320435A0
Authority
IT
Italy
Prior art keywords
acne
treatment
composition
Prior art date
Application number
IT8320435A
Other languages
English (en)
Other versions
IT1194185B (it
IT8320435A1 (it
Inventor
Messina Michele
Original Assignee
Schiapparelli Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schiapparelli Farma filed Critical Schiapparelli Farma
Priority to IT20435/83A priority Critical patent/IT1194185B/it
Publication of IT8320435A0 publication Critical patent/IT8320435A0/it
Priority to EP84200329A priority patent/EP0124147B1/en
Priority to DE19843466647 priority patent/DE3466647D1/de
Priority to US06/593,926 priority patent/US4543351A/en
Priority to DE19843411225 priority patent/DE3411225A1/de
Priority to CA000450953A priority patent/CA1204059A/en
Publication of IT8320435A1 publication Critical patent/IT8320435A1/it
Application granted granted Critical
Publication of IT1194185B publication Critical patent/IT1194185B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT20435/83A 1983-04-01 1983-04-01 Composizione per il trattamento dell'acne IT1194185B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20435/83A IT1194185B (it) 1983-04-01 1983-04-01 Composizione per il trattamento dell'acne
EP84200329A EP0124147B1 (en) 1983-04-01 1984-03-08 Spironolactone containing composition for combating acne
DE19843466647 DE3466647D1 (it) 1983-04-01 1984-03-08
US06/593,926 US4543351A (en) 1983-04-01 1984-03-27 Spironolactone containing composition for combatting acne
DE19843411225 DE3411225A1 (de) 1983-04-01 1984-03-27 Verwendung von spironolacton zur bekaempfung von akne
CA000450953A CA1204059A (en) 1983-04-01 1984-03-30 Spironolactone containing composition for combatting acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20435/83A IT1194185B (it) 1983-04-01 1983-04-01 Composizione per il trattamento dell'acne

Publications (3)

Publication Number Publication Date
IT8320435A0 true IT8320435A0 (it) 1983-04-01
IT8320435A1 IT8320435A1 (it) 1984-10-01
IT1194185B IT1194185B (it) 1988-09-14

Family

ID=11166894

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20435/83A IT1194185B (it) 1983-04-01 1983-04-01 Composizione per il trattamento dell'acne

Country Status (5)

Country Link
US (1) US4543351A (it)
EP (1) EP0124147B1 (it)
CA (1) CA1204059A (it)
DE (2) DE3466647D1 (it)
IT (1) IT1194185B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410348A1 (en) * 1989-07-26 1991-01-30 G.D. Searle & Co. Topical spironolactone composition
JPH05331066A (ja) * 1992-05-25 1993-12-14 Toko Yakuhin Kogyo Kk 尋常性ざ瘡治療用組成物
MX9303557A (es) * 1992-08-06 1994-03-31 Beta Pharm Co Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
US10343436B2 (en) 2006-02-27 2019-07-09 Viavi Solutions Inc. Security device formed by printing with special effect inks
US8102389B2 (en) * 2007-02-14 2012-01-24 International Business Machines Corporation Box casting using an integrated acceleration data structure
US8148327B2 (en) 2007-06-06 2012-04-03 Human Matrix Sciences, Llc Aldosterone induced elastin production
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
US8618084B2 (en) 2008-06-06 2013-12-31 Human Matrix Sciences, Llc Aldosterone induced vascular elastin production
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN104055781A (zh) * 2014-06-16 2014-09-24 南充市中心医院 替硝唑螺内酯乳膏及其制备方法
JP6861634B2 (ja) 2015-03-03 2021-04-21 イー，リチャード，ダブリュ． 眼疾患を処置するための組成物及び方法
US10792293B2 (en) * 2015-07-31 2020-10-06 Hamidreza Kelidari Topical nanodrug formulation
US11524016B2 (en) 2020-07-17 2022-12-13 Amy Thorne Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
FR2366840A1 (fr) * 1976-10-06 1978-05-05 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de betamethasone
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
FI59534C (fi) * 1979-10-31 1981-09-10 Orion Yhtymae Oy Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US4347245A (en) * 1981-05-26 1982-08-31 German Shapiro Spironolactone-containing composition and use thereof
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid

Also Published As

Publication number Publication date
IT1194185B (it) 1988-09-14
DE3466647D1 (it) 1987-11-12
DE3411225C2 (it) 1991-11-07
EP0124147A1 (en) 1984-11-07
IT8320435A1 (it) 1984-10-01
US4543351A (en) 1985-09-24
EP0124147B1 (en) 1987-10-07
DE3411225A1 (de) 1984-10-04
CA1204059A (en) 1986-05-06

Similar Documents

Publication Publication Date Title
IT8147606A0 (it) Composizione per il trattamento topico dell'acne
IT8167845A0 (it) Composizione per il trattamento topico dell'acne
IT8421516A0 (it) Composizioni migliorate per il trattamento della psoriasi.
IT1206707B (it) Apparecchio per l'applicazione di forza.
IT8320435A0 (it) Composizione per il trattamento dell'acne.
IT8322430A0 (it) Composti dell'azetidina.
IT8522425A0 (it) Procedimento di sintesi dell'amikacina.
IT8421342A0 (it) Composizioni e composti per il trattamento dell'adenoma prostatico.
IT1209577B (it) Sintesi dell'aspartame.
IS2902A7 (is) Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis
IT1212097B (it) Sintesi dell'aspartame.
IT8520463A0 (it) Trattamento dell'osteoporosi.
IT8520448A0 (it) Trattamento dell'osteoporosi.
IT8321080A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina.
IT7821264A0 (it) Composizione per il trattamento dell'asma.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
IT1176376B (it) Procedimento per la preparazione di 3, 11-dimepil-2-nonacosanone
IT8167096A0 (it) Bastoncino cosmetico particolarmente per il trattamento dell acne
IT8020016A0 (it) Nuovi medicamenti per il trattamento dell'obesita'.
FR2547159B1 (fr) Appareil d'epandage notamment pour engrais
DE3167587D1 (en) Composition for the treatment of acne
IT8223108A0 (it) Procedimento per la preparazione dell'isosorbide-5-nitrato.
IT1178793B (it) Procedimento per la preparazione di 3,4,5-trimetossi-benzonitrile
IT7825854A0 (it) Procedimento per la purificazione dell'urochinasi.
IT8119219A0 (it) Procedimento per la preparazione dell'l-5-idrossitriptofano.